Youth-appealing features in popular e-cigarette brand advertising in the USA after heightened scrutiny in 2018
Conclusion Even with heightened scrutiny of e-cigarette brands, advertisements still included youth-appealing content such as flavours, fruit imagery and positive sensations. Puff Bar led in all these categories, and it rapidly gained market share after market leader JUUL limited the sales of its flavoured products. Research should continue to monitor the characteristics of e-cigarette advertisements and consider their impact on youth. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Liu, J., Vazquez-Otero, C., Berman, M. L., Stevens, E. M. Tags: Brief report Source Type: research

Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders
Conclusion Smokers with MHDs are not sufficiently represented in RCTs examining the safety and effectiveness of smoking cessation medications. Greater access to clinical trial participation needs to be facilitated for this group to better address access to appropriate pharmacotherapeutic interventions in this vulnerable population. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Talukder, S. R., Lappin, J. M., Boland, V., McRobbie, H., Courtney, R. J. Tags: Open access Review Source Type: research

Systemic biomarkers of exposure associated with ENDS use: a scoping review
Conclusions Consistent, although limited, evidence shows that exclusive ENDS users have elevated levels of biomarkers of certain volatile organic compounds (VOCs; eg, acrylamide and acrylonitrile), metals (eg, cadmium and selenium) and propylene glycol compared with non-users; however, evidence for biomarkers of other toxicants (eg, acrolein, benzene and chromium) is mixed. Biomarkers of most VOCs are lower in ENDS users compared with cigarette smokers, and cigarette smokers who switch to ENDS consistently show reductions in VOC biomarkers. Evidence comparing metal exposures from exclusive ENDS use, cigarette smoking and d...
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Hiler, M., Weidner, A.-S., Hull, L. C., Kurti, A. N., Mishina, E. V. Tags: Review Source Type: research

Risk perceptions and continued smoking as a function of cigarette filter ventilation level among US youth and young adults who smoke
Conclusion Youth and young adults who use higher FV cigarettes perceived their brand as less harmful compared with other brands. However, level of FV was not associated with continued smoking. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Carroll, D. M., Tessier, K. M., Cummings, K. M., O'Connor, R. J., Reisinger, S., Shields, P. G., Stepanov, I. S., Luo, X., Hatsukami, D. K., Rees, V. W. Tags: Original research Source Type: research

Variations in cigarette brand characteristics: can consumers tell the difference?
Conclusions While some clusters of brand varieties provided a noticeably different product for consumers, in many cases design differences within these clusters did not exceed the expected discrimination threshold. This indicates that many products on the market are not discernibly different for consumers, and that proliferation of brand varieties has a non-sensory purpose, such as marketing. Policy makers should consider limiting available brand varieties and regulating design characteristics to reduce product appeal. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Pennings, J. L. A., Ferris Wayne, G., Klerx, W. N. M., Pauwels, C. G. G. M., Talhout, R. Tags: Open access Original research Source Type: research

New tobacco and nicotine products in Latin America and the Caribbean: assessing the market and regulatory environment
Conclusion NTNPs are emerging products in the LAC region. Governments should follow WHO guidance and the decisions of the Conference of Parties to the WHO Framework Convention on Tobacco Control and ban or regulate NTNPs as tobacco products; otherwise NTNPs could create a new generation of tobacco and nicotine users. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Crosbie, E., Severini, G., Beem, A., Tran, B., Sebrie, E. M. Tags: Original research Source Type: research

Framing the policy debate over tobacco control legislation and tobacco taxation in South Africa
Conclusion The dominance of economic arguments opposing tobacco control legislation risks undermining tobacco control progress. Local and global tobacco control advocates should seek to build relationships with media, as well as collate and disseminate effective counterarguments to those advanced by the industry. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Zatonski, M. Z., Egbe, C. O., Robertson, L., Gilmore, A. Tags: Open access Original research Source Type: research

Cigarette dependence is more prevalent and increasing among US adolescents and adults who use cannabis, 2002-2019
Conclusions US individuals who use both cigarettes and cannabis report a higher prevalence of cigarette dependence relative to individuals who use cigarettes and do not use cannabis at virtually all levels of cigarette consumption. Further, cigarette dependence is increasing in the USA both among those who use and do not use cannabis. Given the increase in cannabis use among those using cigarettes, efforts to elucidate the nature of the association between cannabis and cigarette dependence are needed. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Weinberger, A. H., Dierker, L., Zhu, J., Levin, J., Goodwin, R. D. Tags: Original research Source Type: research

Comparing belief in short-term versus long-term consequences of smoking and vaping as predictors of non-use in a 3-year nationally representative survey study of US youth
Conclusions These results support temporal discounting by adolescents and young adults and suggest health communication efforts aiming to reduce youth tobacco use should emphasise shorter term consequences. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Jesch, E., Kikut, A. I., Hornik, R. Tags: Original research Source Type: research

Objective and perceived measures of tobacco marketing are uniquely associated with cigar use
Conclusions Tobacco control efforts should consider both perceived and objective exposure to tobacco marketing and unique associations with blunt use to prevent cigar use. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Kowitt, S. D., Finan, L. J., Lipperman-Kreda, S. Tags: Original research Source Type: research

IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation
Conclusions Regulatory efforts must be informed by ongoing surveillance of IQOS marketing efforts and its impacts, particularly how specific consumer subgroups (eg, tobacco non-users, women, young people) are impacted by marketing exposure. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Berg, C. J., Romm, K. F., Bar-Zeev, Y., Abroms, L. C., Klinkhammer, K., Wysota, C. N., Khayat, A., Broniatowski, D. A., Levine, H. Tags: Original research Source Type: research

Policy incoherence and tobacco control in Indonesia: an analysis of the national tobacco-related policy mix
Discussion Political will differs according to ministerial mandates and priorities, fostering a fragmented policy approach and undermining the development of a coherent response. Without political will from the president or national parliament to create an overarching framework for tobacco control, either via ratification of the Framework Convention on Tobacco Control or another mechanism, there remains no formal impetus for intragovernmental cooperation. Nonetheless, this analysis reveals some government progress and ‘pressure points’ that advocates can focus on to promote tobacco control policies within the c...
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Kramer, E., Ahsan, A., Rees, V. W. Tags: Editor's choice Original research Source Type: research

Worldwide news and comment
All articles written by Karen Evans-Reeves, Ruth Canty or Manuja Perera unless otherwise attributed. Ideas and items for News Analysis should be sent to k.a.evans-reeves@bath.ac.uk South AmericaUruguay: civil society challenges tobacco industry interference Over the past few decades, Uruguay has secured great achievements in tobacco control, followed in turn, by favourable health outcomes. After becoming the first indoor-smoke-free country in the Americas region in 2006, a comprehensive tobacco control law was passed in 2008. By this time, the Uruguayan government had already enacted the world’s largest pictorial hea...
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Evans-Reeves, K., Canty, R., Perera, M. Tags: TC News analysis, Open access Source Type: research

Policy incoherence and unwillingness of the Indonesian government to curb its alarming tobacco epidemic
Globally, countries recognised the detrimental effects of tobacco use when they collectively agreed to enhance tobacco control measures through the adoption of the WHO Framework Convention for Tobacco Control (WHO-FCTC). Positive progress has been made by many countries that have showed significant declines in their smoking rates. Effective tobacco control measures require strong political will and leadership, alongside concerted efforts across sectors. Those prerequisites are practically absent in Indonesia, a country with more than 65 million adult smokers and over 22 million youth smokers, which is also the only country...
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Astuti, P. A. S. Tags: Open access Editorial Source Type: research

'Beyond nicotine marketing strategies: Big Tobacco diversification into the vaping and cannabis product sectors
Tobacco sales in Canada and the USA have stagnated.1 2 Although denormalisation strategies have reframed smoking (and smokers) as socially unacceptable,3–6 these attitudes appear to apply uniquely to smoked tobacco. Cannabis now represents notable opportunities for tobacco companies, with recreational cannabis becoming legalised federally in Canada (effective October 2018) and increasingly at the state level in the USA. While the social acceptability of cigarette smoking has declined over time, cannabis use has become chic and desirable. For example, Barneys—a set of high-end US department stores that were know...
Source: Tobacco Control - April 20, 2023 Category: Respiratory Medicine Authors: Dewhirst, T. Tags: Industry watch Source Type: research